Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis

G Head, Michael and Goss, Sian and Gelister, Yann and Alegana, Victor and J Brown, Rebecca and C Clarke, Stuart and R A Fitchett, Joseph and Atun, Rifat and G Scott, J Anthony and Newell, Marie-Louise and S Padmadas, Sabu and J Tatem, Andrew (2017) Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis. The Lancet Global Health, 5 (8). e772-e781. ISSN 0140-6736

[img] Text
PIIS2214109X17302450.pdf

Download (844kB)
Official URL: http://www.thelancet.com/journals/langlo/article/P...

Abstract

Background Total domestic and international funding for malaria is inadequate to achieve WHO global targets in burden reduction by 2030. We describe the trends of investments in malaria-related research in sub-Saharan Africa and compare investment with national disease burden to identify areas of funding strength and potentially neglected populations. We also considered funding for malaria control. Methods Research funding data related to malaria for 1997–2013 were sourced from existing datasets, from 13 major public and philanthropic global health funders, and from funding databases. Investments (reported in US$) were considered by geographical area and compared with data on parasite prevalence and populations at risk in sub- Saharan Africa. 45 sub-Saharan African countries were ranked by amount of research funding received. Findings We found 333 research awards totalling US$814·4 million. Public health research covered $308·1 million (37·8%) and clinical trials covered $275·2 million (33·8%). Tanzania ($107·8 million [13·2%]), Uganda ($97·9 million [12·0%]), and Kenya ($92·9 million [11·4%]) received the highest sum of research investment and the most research awards. Malawi, Tanzania, and Uganda remained highly ranked after adjusting for national gross domestic product. Countries with a reasonably high malaria burden that received little research investment or funding for malaria control included Central African Republic (ranked 40th) and Sierra Leone (ranked 35th). Congo (Brazzaville) and Guinea had reasonably high malaria mortality, yet Congo (Brazzaville) ranked 38th and Guinea ranked 25th, thus receiving little investment. Interpretation Some countries receive reasonably large investments in malaria-related research (Tanzania, Kenya, Uganda), whereas others receive little or no investments (Sierra Leone, Central African Republic). Research investments are typically highest in countries where funding for malaria control is also high. Investment strategies should consider more equitable research and operational investments across countries to include currently neglected and susceptible populations.

Item Type: Article
Subjects: WA Public Health
Divisions: Faculty of Medicin
Depositing User: Touba Derakhshande
Date Deposited: 30 Aug 2017 06:52
Last Modified: 30 Aug 2017 06:52
URI: http://eprints.bpums.ac.ir/id/eprint/5779

Actions (login required)

View Item View Item